Industrial Grade 1,3-Dibromo-5-Methylbenzene: Purity Standards and COA Validation

• Verified Assay: Consistent quality control ensuring assay levels exceed 98% via GC/HPLC analysis.
• Impurity Control: Rigorous monitoring of isomeric contaminants and residual solvents in brominated toluene batches.
• Documentation: Comprehensive Batch Specific COA provided for every industrial shipment to ensure regulatory compliance.

In the landscape of fine chemical manufacturing, the reliability of building blocks is paramount for downstream pharmaceutical success. 1,3-Dibromo-5-methylbenzene, also known commercially as 3,5-Dibromotoluene (CAS: 1611-92-3), serves as a critical intermediate in the construction of complex organic molecules. For process chemists and procurement specialists, securing material with defined industrial purity is not merely a preference but a necessity for reproducible reaction yields. As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. emphasizes the importance of transparent quality assurance protocols when sourcing this brominated aromatic compound.

The molecular formula C7H6Br2 and a molecular weight of approximately 249.93 g/mol define the physical characteristics of this substance. However, beyond basic specifications, the true value lies in the consistency of the supply chain. Variations in purity can significantly impact catalytic processes, particularly in cross-coupling reactions where halogenated precursors are utilized. Therefore, understanding the analytical data behind the product is essential for maintaining process integrity.

Verifying Assay Levels Above 98% via GC/HPLC

When evaluating potential suppliers for 3,5-Dibromotoluene, the primary metric of quality is the assay percentage. Industrial grades typically demand a minimum purity of 98%, though high-performance applications may require further refinement. Verification of this assay is predominantly achieved through Gas Chromatography (GC) or High-Performance Liquid Chromatography (HPLC). These analytical methods separate the target compound from potential by-products, providing a quantitative measure of purity.

For bulk procurement, it is crucial to request chromatograms alongside the certificate of analysis. A sharp, singular peak in the GC trace indicates a high degree of homogeneity, whereas shoulder peaks or additional minor peaks suggest the presence of isomers or incomplete reaction products. At NINGBO INNO PHARMCHEM CO.,LTD., our manufacturing process is optimized to minimize these by-products, ensuring that the final bulk price reflects value without compromising on chemical integrity. Consistent assay levels above 98% reduce the need for costly downstream purification steps, thereby improving the overall economics of the synthetic pathway.

Understanding Impurity Profiles in Industrial Grades

Beyond the main assay, a thorough understanding of the impurity profile is vital for risk management in synthesis. Brominated toluene derivatives can contain specific impurities related to their production history. Common contaminants include residual solvents, heavy metals from catalytic systems, and isomeric by-products such as other Dibromotoluene isomer variations. The position of the bromine atoms on the benzene ring significantly affects reactivity; therefore, the presence of 2,4- or 2,6-isomers can lead to unintended side reactions.

Residual solvent analysis is another critical component of the quality profile. Solvents used during crystallization or extraction must be reduced to levels compliant with ICH Q3C guidelines. Furthermore, heavy metal content, often arising from bromination agents or catalysts, must be monitored to ensure safety in pharmaceutical applications. When optimizing a synthesis route, knowing the exact impurity profile allows chemists to adjust parameters effectively. This level of detail distinguishes standard commercial material from premium industrial grades suitable for sensitive drug substance manufacturing.

Requesting and Validating Batch Specific COA Documentation

The Certificate of Analysis (COA) is the definitive document governing the acceptance of chemical raw materials. For 1,3-Dibromo-5-methylbenzene, a valid COA must be batch-specific, linking the test results directly to the production lot number. Generic COAs that cover multiple batches are insufficient for rigorous quality control environments. Key data points on the COA should include the CAS number (1611-92-3), appearance, melting point, assay percentage, and limits for specific impurities.

Validation of this documentation involves cross-referencing the provided data with internal quality standards. Procurement teams should ensure that the testing methods listed on the COA are comparable to internal methodologies to avoid discrepancies. Technical support from the manufacturer is invaluable during this phase, as they can provide clarification on testing protocols or offer additional data such as NMR spectra or mass spectrometry results upon request. Fast delivery of these documents alongside the physical shipment ensures that materials can be cleared through quality control warehouses without unnecessary delays.

In summary, securing high-quality 3,5-Dibromotoluene requires a focus on analytical verification, impurity management, and documentation integrity. By prioritizing these factors, manufacturers can ensure stable production schedules and high-yield reactions. Partnering with an established entity like NINGBO INNO PHARMCHEM CO.,LTD. provides access to reliable custom synthesis capabilities and consistent supply chains. Whether for large-scale production or specialized research, the emphasis must remain on verified data and transparent communication to maintain the highest standards of chemical manufacturing.

Parameter	Specification	Test Method
CAS Number	1611-92-3	Registry Verification
Molecular Formula	C7H6Br2	Calculated
Purity (Assay)	≥ 98.0%	GC / HPLC
Appearance	White to Off-White Solid	Visual Inspection
Residual Solvents	Compliant with ICH Q3C	GC Headspace
Heavy Metals	≤ 10 ppm	ICP-MS